Women are continuing to suffer because of severe shortages of hormone replacement therapy (HRT) - despite signs that stocks of some types are starting to improve.
Women experiencing the menopause, fertility problems, miscarriage and pregnancy loss, menstrual health and gynecological conditions in the workplace will be supported to remain in or return to the workplace by a multi-million pound funding boost to voluntary, community and social enterprise (VCSE) organizations.